MC
Merck & Co Portfolio holdings
AUM
$228M
1-Year Est. Return
13.21%
1 Year Est. Return
-13.21%
AUM
$228M
AUM Growth
+$12.4M
(+5.8%)
Holding
13
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Personalis
PSNL
$703M
| $91.6M | 40.16% |
14,044,943
|
|
||
2
Moderna
MRNA
$12.1B
| $59.6M | 26.15% |
2,308,190
|
|
||
3
Kymera Therapeutics
KYMR
$6.37B
| $43.7M | 19.17% |
772,165
|
|
||
4
Alector
ALEC
$152M
| $10.5M | 4.6% |
3,545,719
|
|
||
5
Entrada Therapeutics
TRDA
$419M
| $10.1M | 4.43% |
1,739,768
|
|
||
|
EVAX
6
Evaxion A/S
EVAX
$48M
| $4.57M | 2% |
1,214,126
|
|
||
7
Sutro Biopharma
STRO
$76.1M
| $2.37M | 1.04% |
2,723,509
|
|
||
8
Viridian Therapeutics
VRDN
$3.02B
| $2.02M | 0.88% |
93,414
|
|
||
|
LVTX
9
DELISTED
LAVA Therapeutics
LVTX
| $1.79M | 0.79% |
1,149,345
|
|
||
10
Xilio Therapeutics
XLO
$34.1M
| $1.25M | 0.55% |
1,483,758
|
|
||
|
CARM
11
DELISTED
Carisma Therapeutics
CARM
| $404K | 0.18% |
1,473,240
|
|
||
|
NEUP
12
Neuphoria Therapeutics
NEUP
$20.9M
| $118K | 0.05% |
10,027
|
|
||
|
HURA
13
TuHURA Biosciences
HURA
$50.1M
| $34.6K | 0.02% |
13,950
|
|